I’m excited to formally announce that we have a new partner: Kira Noodleman. Garrett, Tim and I have long been impressed with Kira’s intellect, curiosity and energy and this promotion acknowledges the central role she has already played in making Bee Partners and our portfolio stronger. Kira’s approach has been that of a partner since … Read more
As COVID-19 drags into another year, we feel lucky that from our vantage point we see a silver lining. 2021 was a year in which we, along with much of the world, learned whether we could stand steady on the ever-shifting grounds that have become our new normal. It’s been said that “luck is where … Read more
When our portfolio company Future Fields set out to address the world’s reliance on animal protein as a food source, they intended to produce lab-grown chicken. After four months of intense experimentation, their only product was a chicken nugget that cost $3,000 a pound–not a viable solution to world hunger. A lot of companies might … Read more
Stunning, unprecedented, chaotic…relentless. At some point, each of us at Bee Partners used those–and many other colorful–words to make sense of 2020. But, we also tested our ability to pivot quickly and effectively in order to provide the support our portfolio companies needed as we all adapted to our new reality. Perhaps surprisingly, 2020 brought a … Read more
Deeptech’s scientific and tech-innovation demands bring unique challenges for early-stage companies and their investors. Bee Partners has a long-standing interest in deeptech. We all four have a little science geek in us and we’ve witnessed through our investments the world-changing power of deeply researched and singularly applied solutions that only deeptech can provide. Our deeptech … Read more
Building Technology at the Genetic Level Executive Summary Our ability to design and engineer biological components and systems at the genetic level has increased substantially over the previous decade. In 2010, the first self-replicating cell was created from artificial DNA, which was built by researchers out of chemically synthesized oligonucleotides. Since then, the cost per … Read more